NCT04774185

Brief Summary

Sonova Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Sonova Hearing Systems undergo a final quality control in terms of clinical trials. This is a confirmatory study, investigating benefits of a modified hearing aid loudspeaker. This will be a clinical investigation which will be conducted mono centric at National Acoustic Laboratories a well known institution with exceptional experience (Australia).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 1, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

April 26, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2022

Completed
Last Updated

March 28, 2023

Status Verified

April 1, 2021

Enrollment Period

12 months

First QC Date

February 25, 2021

Last Update Submit

March 24, 2023

Conditions

Keywords

Acoustical Coupling

Outcome Measures

Primary Outcomes (1)

  • Evaluation of speech intelligibility and sound quality for different loudspeaker

    The Primary Outcome measure of this study is the comparison of the standard hearing aid loudspeaker with the modified one in regard to speech intelligibility in a noisy environment and sound quality in a quiet situation. The speech intelligibility will be measured using a speech test in dB SRT and the sound quality will be assessed by subjective rating, using percentage of satisfaction from "very satisfied (100)" to "very unsatisfied (0)".

    2 weeks

Secondary Outcomes (3)

  • Evaluation of listening effort for different loudspeaker.

    2 weeks

  • Evaluation of sound quality of own voice for different loudspeaker.

    2 weeks

  • Evaluation of sound quality of streamed signals for different loudspeaker

    2 weeks

Study Arms (2)

New hearing aid loudspeaker

EXPERIMENTAL

The new hearing aid loudspeaker is a loudspeaker system with a modified acoustic coupling approach which will be fitted based on the participants' individual ear anatomy.

Device: New hearing aid loudspeaker

Standard hearing aid loudspeaker

ACTIVE COMPARATOR

The hearing aid loudspeaker is a loudspeaker system with the existing acoustic coupling approach which will be fitted based on the participants' individual ear anatomy.

Device: Standard hearing aid loudspeaker

Interventions

The new hearing aid loudspeaker will be fitted to the participants individual ear anatomy and hearing loss.

New hearing aid loudspeaker

The standard hearing aid loudspeaker will be fitted to the participants individual ear anatomy and hearing loss.

Standard hearing aid loudspeaker

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult hearing impaired persons (minimum age: 18 years, mild to moderate Hearing loss)
  • Good written and spoken English language skills
  • Healthy outer ear
  • Ability to fill in a questionnaire (p/eCRF) conscientiously
  • Willingness to wear Receiver in Canal hearing aids
  • Informed Consent as documented by signature
  • Normal cognitive abilities

You may not qualify if:

  • Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product
  • Limited mobility and not in the position to attend weekly appointments in Sydney (AUS)
  • Limited ability to describe listening impressions/experiences and the use of the hearing aid
  • Inability to produce a reliable hearing test result
  • Known psychological problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Acoustic Laboratories

Sydney, Australia

Location

Related Links

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jorge Meijra, PhD

    National Acoustic Laboratories

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2021

First Posted

March 1, 2021

Study Start

April 26, 2021

Primary Completion

April 25, 2022

Study Completion

April 25, 2022

Last Updated

March 28, 2023

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations